About
Mark Pulido has more than four decades of leadership experience across health IT, health services, pharmaceuticals, diagnostics, and private equity, having served as CEO of five companies. He was President and CEO of ABILITY, a cloud-based healthcare provider platform acquired by Inovalon, and previously held CEO roles at McKesson Corporation, Novartis Pharmaceuticals Corporation (USA), BenefitPoint, and Red Line Healthcare Corporation. He has also served on the boards of Inovalon, Quidel, and other healthcare and technology companies.
Invests in
Cloud ComputingDigital HealthHealthtech
Experience
- Gainwell TechnologiesMember Board of Directorscurrent2024 β present
- Cressey & CompanyDistinguished Executive Councilcurrent2022 β present
- Alix VenturesOperating Partnercurrent2020 β presentSan Francisco, California, United States
- Pulido~Walker Estate Vineyards & WineryProprietor & co-Foundercurrent2006 β presentNapa Valley, California
- InovalonMember of the Board of Directors2018 β 2021
- ABILITY NetworkChairman, President & CEO2015 β 2018
- ABILITY NetworkMember of the Board of Directors2011 β 2018
- Freeman Spogli & Co.Industry Executive2004 β 2015
- QuidelChairman of the Board of Directors2004 β 2015
- Benefit Point Inc.Chairman, President, & CEO2000 β 2002
- McKessonPresident & CEO1996 β 1999San Francisco Bay Area
- NovartisPresident & CEO1994 β 1996United States
- RedLine HealthcareChairman, President, & CEO1990 β 1994
Education
- University of ArizonaBachelor of Science (BS), Pharmacy
- University of MinnesotaMaster of Science (M.S.), Pharmacy Administration
Skills & more
Public Speaking9Strategic Planning47Negotiation4Management32Strategy63Product Development12Sales Management13Customer Service9Business Development14Budgets4Marketing Strategy25Team Building11
+12 more
HealthcareResearchHealthcare Information TechnologyWinePharmacyManaged CareInformaticsLifesciencesSellingHealthcare IndustryInfectious DiseasesSalesFrom Mark's professional profile.
Same school
Also attended University of Arizona73
Tom KalinskeInvestor at Alsop Louie PartnersEmily FritzePartner at The Westly GroupLaura SageDirector, Marketing & Investor Relations at Windham Capital PartnersDylan TaylorSSV II Investment Committee at Seraphim SpaceRay CostantiniVenture Partner at Suncoast VenturesDr. Julie PullenChief Scientist and Partner at Cerulean Ventures
+ 67 more
Also attended University of Minnesota83
Madeline PopeSenior Associate, Platform & Marketing at March Capital PartnersNate LeeFounder and Chief Information Security Officer at Scale Venture PartnersRichard HeymanVenture Partner at ARCH Venture PartnersJohn BergstromInvestor at Mairs & Power VCMark GorenbergInvestor at Zetta Venture PartnersRobin BorgInvestor at TRANSFORMATION CAPITAL
+ 77 more
Shared employers
Also worked at Inovalon3
Also worked at ABILITY Network1
Also worked at Freeman Spogli & Co.26
Travis NelsonEmeritus Partner at NEW VISTA CAPITALPreston PhillipsPartner at Peterson Venture PartnersKellie BarrancoVice President at Freeman SpogliSpencer BorwickSenior Associate at Freeman SpogliBrad BrutocaoPartner at Freeman SpogliShaun CaesarPartner at Freeman Spogli
+ 20 more
Also worked at McKesson25
Nancy BrownAdvisor at Oncology VenturesJason ShookChief Operating Officer at Oncology VenturesDiana VerrilliGeneral Manager, Navista (a Cardinal Health company) at Oncology VenturesKendra PerlitzChief Operating Officer at Playground GlobalMichael SandersonFormer CEO, Medix Infusion Hamilton at Empactful CapitalChing-Ping LinPartner & COO at Orbit Startups
+ 19 more
Investments
Board seats
Charles SchwabImationInovalonQuidelSmile Brands GroupSunrise Medical
Per the firm's website.
Colleagues at Alix Ventures
Amee Kapadia
Investor at Alix Ventures
Brian Fiske
SAB Member - Drug Development at Alix Ventures
Chas Pulido
Founder & General Partner at Alix Ventures
Daniel Delubac
SAB Member - Diagnostics/Lab Services at Alix Ventures
Dennis Gong
Investor at Alix Ventures
Eric Dai
Investor at Alix Ventures
Gia Oscherwitz
Investor at Alix Ventures
Jake Becraft
SAB Member - Syn Bio / CGT at Alix Ventures



%20(002)%20(1).jpg)





























